ECL assay is unique in its ability to detect autoantibodies of all immunoglobulin classes including IgA, IgG, and IgM [17], which is helpful in individuals with selective IgA deficiency and early detection on the initial stage of antibody development with IgM only at seroconversion. This evidence concerns the gene CD79A and selective IgA deficiency disease.